Vortex Web Site
of the Dialysis World

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

B Braun's Dialog™ sets new standards for safety, efficiency and reliability.

Reduce Reuse Recycle, It's That Simple Medivators.

Better Water, Inc. - The one call to make for water treatment & central delivery systems, portables, products & consumables.
G.I.A. Medical - Over 40 years experience ensuring refurbished dialysis machines meet OEM specifications at wholesale prices.
Daily Highlights
Company of the Day:  Nipro Medical
Since January 1999, RenalWEB has been the premier Internet location for information on dialysis-related products and services. Features include:
 
Dialysis Yellow Pages
  Dialysis Product Showcase
  Recent Daily Highlights
 
View the Latest Feature Ads
Rockwell -
Triferic
AmeriWater
Heat Disinfect RO
for Single Patient
Charles River -
Endotoxin &
Microbial Detection

Integrated Biomedical
Technology - Dialysis
Test Strips

B. Braun -
Hemodialysis
System Supplies

Nephros -
Ultrafiltration
Dravon Medical -
Blood Line Clamps
Diasol -
Hemodialysis Chairs
Advertising Opportunities
FacebookTwitter
  Jan. 18, 2017
FDA Class II Recall for over 205,000 Fresenius 2008 Dialysis Machines due to UF Rate Errors: "When the UF Rate, Goal or Time is adjusted using the up and down arrow keys, and the change is cancelled by using the esc key, the cancelled UF Rate is actually being executed rather than rate displayed on the machine"
Fresenius Medical Care North America Announces New CEO Bill Valle
News release.
Patient Advocacy Organizations (PAOs), Industry Funding, and Conflicts of Interest
Free, full-text, New Online article and editorial from JAMA Internal Medicine.

"Given the growing ability of PAOs to influence health care policy and practice, their financial practices and safeguards demand the same degree of scrutiny applied to other key actors in the health care landscape."

"In our view this new work demonstrates an urgent need for patient advocacy organizations to explicitly focus much more on representing the interests of patients and citizens, rather than serving—inadvertently or otherwise—the interests of their industry sponsors."

Editor's note: There are a few PAOs in the US dialysis field that primarily function to increase the revenues of the large for-profit dialysis providers. Most other PAOs take money from industry to attempt to provide some of the components of well-patient dialysis care that the for-profit companies do not provide. This allows these companies to avoid most of the costs and responsibilities for a well-patient model of dialysis care. This keeps US dialysis care minimal, stagnant, and failing most patients.
Financial Ties of Principal Investigators and Randomized Controlled Trial Outcomes: Cross Sectional Study
Free, full-text article and editorial from The BMJ.

"Financial ties of principal investigators were independently associated with positive clinical trial results. These findings may be suggestive of bias in the evidence base."

"Trials with industry funding or authors with financial ties should be interpreted with caution until all relevant information is fully disclosed and easily accessible."
Kidney Disease Patients Have Higher Out-of-Pocket Costs than Stroke and Cancer Patients
Press release from Loyola University Health System. Free, Open Access article from BMC Nephrology.
CDC: Kidney Failure from Diabetes down 54% among American Indians
News brief from AHANews.
Free, Open Access Articles from BMC Nephrology:
Thyroid Testing in Kidney Disease – Should We Be Routinely Assessing?
Posting from the AJKD blog.
PDI in Press Abstracts:
The Large Spectrum of Renal Disease in Diabetic Patients
Free, full-text, Advance Access editorial testing 123 from Clinical Kidney Journal.
(Re)Building a Kidney
JASN Express abstract.
Treatment of HCV in Renal Transplant Patients with Peginterferon and Ribavirin: Long-Term Follow-Up
First Online abstract from Clinical and Experimental Nephrology.
Weekly Diabetes Drug Provides Similar Benefits to Daily Version
Drugmakers Manipulate Orphan Drug Rules To Create Prized Monopolies
Article from Kaiser Health News. Additional articles:
Free, Full-Text Articles from the Journal of the American Medical Association:
CBO Report: Obamacare Repeal Could Bring Many More Uninsured, Higher Premiums
Article from HealthDay.
 

Previous News Stories
Why U.S. Dialysis Care Has Been Stagnant
Understanding Tassin
Nephrologists Can't Have It Both Ways (2015)
Ten Issues Nephrologists Do Not Want To Discuss with Dialysis Patients (2014)
The Missing Half of Excellence in
Dialysis Care 2013)
Human-Centered Care (2013)
Fix Dialysis
Boston ESRD Conference (2009)
New Views (2008)
Discussion Boards
Classified Ads
Journals
Conferences
Stocks
Legislation
Disclaimer
Links
Dialysis Topics: Internet Resources
 
   

Read Legal Disclaimer

Copyright© 2017 RenalWEB. All rights reserved.

Except where noted, no material within the RenalWEB web sites can be copied, duplicated, or reproduced in any form without written consent from RenalWEB.